Elevated risk of papillary thyroid cancer in Korean patients with Hashimoto's thyroiditis

Head and Neck

Volumn 33, Issue 5, 2011, Pages 691-695

  Kim, Kyung Won ^a,b   Park, Young Joo ^a,c   Kim, Eun Hye ^c   Park, So Yeon ^a,c   Park, Do Joong ^a,c   Ahn, Soon Hyun ^a,c   Jang, Hak C ^a,c   Cho, Bo Youn ^a  

^a Seoul National University   (South Korea)

^b Seoul National University Hospital Healthcare System Gangnam Center   (South Korea)

^c Seoul National University Bundang Hospital   (South Korea)

Author keywords

Hashimoto's thyroiditis; papillary thyroid cancer; thyroid cancer; thyroid stimulating hormone; thyrotropin

Indexed keywords

LEVOTHYROXINE; THYROGLOBULIN ANTIBODY; THYROID PEROXIDASE ANTIBODY; THYROTROPIN; THYROXINE;

ADULT; ANTIBODY BLOOD LEVEL; ARTICLE; BENIGN TUMOR; CANCER RISK; COMPARATIVE STUDY; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; HASHIMOTO DISEASE; HISTOPATHOLOGY; HUMAN; IMMUNORADIOMETRIC ASSAY; KOREA; MAJOR CLINICAL STUDY; MALE; METASTASIS; MICROSCOPY; MULTIPLE CANCER; PRIORITY JOURNAL; RISK FACTOR; THYROID FOLLICULAR CARCINOMA; THYROID GLAND; THYROID PAPILLARY CARCINOMA; THYROIDECTOMY; THYROTROPIN BLOOD LEVEL; THYROXINE BLOOD LEVEL; TUMOR VOLUME;

ADENOCARCINOMA, FOLLICULAR; AUTOANTIBODIES; CARCINOMA, PAPILLARY; FEMALE; HASHIMOTO DISEASE; HUMANS; IODIDE PEROXIDASE; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; REPUBLIC OF KOREA; RISK FACTORS; SEX FACTORS; THYROGLOBULIN; THYROID NEOPLASMS; THYROID NODULE; THYROIDECTOMY; THYROTROPIN; THYROXINE;

EID: 79954537672     PISSN: 10433074     EISSN: 10970347     Source Type: Journal    
DOI: 10.1002/hed.21518     Document Type: Article

References (36)

1. Balkwill F, Mantovani A,. Inflammation and cancer: back to Virchow? Lancet 2001; 357: 539-545. (Pubitemid 32173595)
2. Bernatsky S, Ramsey-Goldman R, Clarke A,. Malignancy and autoimmunity. Curr Opin Rheumatol 2006; 18: 129-134. (Pubitemid 43740384)
3. Jameson J, Weetman A,. Disorders of the Thyroid Gland. In:, Fauci A, Braunwald E, Kasper D, et al, editors. Harrison's Principles of Internal Medicine. 17th ed. McGraw-Hill; 2008. pp 2224-2247.
4. Dailey ME, Lindsay S, Skahen R,. Relation of thyroid neoplasms to Hashimoto disease of the thyroid gland. AMA Arch Surg 1955; 70: 291-297.
5. Hirabayashi RN, Lindsay S,. The relation of thyroid carcinoma and chronic thyroiditis. Surg Gynecol Obstet 1965; 121: 243-252.
6. Singh B, Shaha AR, Trivedi H, Carew JF, Poluri A, Shah JP,. Coexistent Hashimoto's thyroiditis with papillary thyroid carcinoma: impact on presentation, management, and outcome. Surgery 1999; 126: 1070-1076; discussion 1076-1077.
7. Ott RA, McCall AR, McHenry C, et al. The incidence of thyroid carcinoma in Hashimoto's thyroiditis. Am Surg 1987; 53: 442-445. (Pubitemid 17122376)
8. Okayasu I, Fujiwara M, Hara Y, Tanaka Y, Rose NR,. Association of chronic lymphocytic thyroiditis and thyroid papillary carcinoma. A study of surgical cases among Japanese, and white and African Americans. Cancer 1995; 76: 2312-2318.
9. Haymart MR, Repplinger DJ, Leverson GE, et al. Higher serum thyroid stimulating hormone level in thyroid nodule patients is associated with greater risks of differentiated thyroid cancer and advanced tumor stage. J Clin Endocrinol Metab 2008; 93: 809-814. (Pubitemid 351398557)
10. Holm LE, Blomgren H, Löwhagen T,. Cancer risks in patients with chronic lymphocytic thyroiditis. N Engl J Med 1985; 312: 601-604. (Pubitemid 15133674)
11. Rago T, Di Coscio G, Ugolini C, et al. Clinical features of thyroid autoimmunity are associated with thyroiditis on histology and are not predictive of malignancy in 570 patients with indeterminate nodules on cytology who had a thyroidectomy. Clin Endocrinol (Oxf) 2007; 67: 363-369. (Pubitemid 47283831)
12. Crile G Jr,. Struma lymphomatosa and carcinoma of the thyroid. Surg Gynecol Obstet 1978; 147: 350-352. (Pubitemid 9008502)
13. Boelaert K, Horacek J, Holder RL, Watkinson JC, Sheppard MC, Franklyn JA,. Serum thyrotropin concentration as a novel predictor of malignancy in thyroid nodules investigated by fine-needle aspiration. J Clin Endocrinol Metab 2006; 91: 4295-4301. (Pubitemid 44833401)
14. Boelaert K,. The association between serum TSH concentration and thyroid cancer. Endocr Relat Cancer 2009; 16: 1065-1072.
15. Jin J, Machekano R, McHenry CR,. The utility of preoperative serum thyroid-stimulating hormone level for predicting malignant nodular thyroid disease. Am J Surg 2010; 199: 294-297; discussion 298.
16. Haymart MR, Glinberg SL, Liu J, Sippel RS, Jaume JC, Chen H,. Higher serum TSH in thyroid cancer patients occurs independent of age and correlates with extrathyroidal extension. Clin Endocrinol (Oxf) 2009; 71: 434-439.
17. Repplinger D, Bargren A, Zhang YW, Adler JT, Haymart M, Chen H,. Is Hashimoto's thyroiditis a risk factor for papillary thyroid cancer? J Surg Res 2008; 150: 49-52.
18. Boi F, Lai ML, Marziani B, Minerba L, Faa G, Mariotti S,. High prevalence of suspicious cytology in thyroid nodules associated with positive thyroid autoantibodies. Eur J Endocrinol 2005; 153: 637-642. (Pubitemid 41672409)
19. Pacini F, Schlumberger M, Dralle H, et al. European consensus for the management of patients with differentiated thyroid carcinoma of the follicular epithelium. Eur J Endocrinol 2006; 154: 787-803. (Pubitemid 43997716)
20. Cooper DS, Doherty GM, Haugen BR, et al. Management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid 2006; 16: 109-142.
21. Kim WB, Kim TY, Kwon HS, et al. Management guidelines for patients with thyroid nodules and thyroid cancer. J Korean Soc Endocrinol 2007; 22: 157-187.
22. Hollowell JG, Staehling NW, Flanders WD, et al. Serum TSH, T(4), and thyroid antibodies in the United States population (1988 to 1994): National Health and Nutrition Examination Survey (NHANES III). J Clin Endocrinol Metab 2002; 87: 489-499. (Pubitemid 34158210)
23. Konno N, Makita H, Yuri K, Iizuka N, Kawasaki K,. Association between dietary iodine intake and prevalence of subclinical hypothyroidism in the coastal regions of Japan. J Clin Endocrinol Metab 1994; 78: 393-397. (Pubitemid 24061759)
24. Carayon P, Thomas-Morvan C, Castanas E, Tubiana M,. Human thyroid cancer: membrane thyrotropin binding and adenylate cyclase activity. J Clin Endocrinol Metab 1980; 51: 915-920. (Pubitemid 10024755)
25. Ichikawa Y, Saito E, Abe Y, Homma M, Muraki T,. Presence of TSH receptor in thyroid neoplasms. J Clin Endocrinol Metab 1976; 42: 395-398.
26. Pujol P, Daures JP, Nsakala N, Baldet L, Bringer J, Jaffiol C,. Degree of thyrotropin suppression as a prognostic determinant in differentiated thyroid cancer. J Clin Endocrinol Metab 1996; 81: 4318-4323. (Pubitemid 26412036)
27. Takashima N, Niwa Y, Mannami T, Tomoike H, Iwai N,. Characterization of subclinical thyroid dysfunction from cardiovascular and metabolic viewpoints: the Suita study. Circ J 2007; 71: 191-195. (Pubitemid 46182691)
28. Guan H, Shan Z, Teng X, et al. Influence of iodine on the reference interval of TSH and the optimal interval of TSH: results of a follow-up study in areas with different iodine intakes. Clin Endocrinol (Oxf) 2008; 69: 136-141. (Pubitemid 351863590)
29. Hamilton TE, Davis S, Onstad L, Kopecky KJ,. Thyrotropin levels in a population with no clinical, autoantibody, or ultrasonographic evidence of thyroid disease: implications for the diagnosis of subclinical hypothyroidism. J Clin Endocrinol Metab 2008; 93: 1224-1230. (Pubitemid 351519714)
30. Teng W, Shan Z, Teng X, et al. Effect of iodine intake on thyroid diseases in China. N Engl J Med 2006; 354: 2783-2793. (Pubitemid 43974196)
31. Park HY, Lee SI, Kim WB, et al. A study on the urinary iodine excretion in normal subjects and patients with thyroid disease. J Korean Soc Endocrinol 1995; 10: 386-394.
32. Cho YW, Kim YS, Baick SH, et al. Analysis of daily intake and urinary excretion of iodine in normal control and patient with thyroid disease. J Korean Soc Endocrinol 1994; 9: 307-317.
33. Kim JY, Moon SJ, Kim KR, Sohn CY, Oh JJ,. Dietary iodine intake and urinary iodine excretion in normal Korean adults. Yonsei Med J 1998; 39: 355-362. (Pubitemid 28419010)
34. Harach HR, Ceballos GA,. Thyroid cancer, thyroiditis and dietary iodine: a review based on the Salta, Argentina model. Endocr Pathol 2008; 19: 209-220.
35. Larson SD, Jackson LN, Riall TS, et al. Increased incidence of well-differentiated thyroid cancer associated with Hashimoto thyroiditis and the role of the PI3k/Akt pathway. J Am Coll Surg 2007; 204: 764-773; discussion 773-775. (Pubitemid 46661188)
36. Kang DY, Kim KH, Kim JM, et al. High prevalence of RET, RAS, and ERK expression in Hashimoto's thyroiditis and in papillary thyroid carcinoma in the Korean population. Thyroid 2007; 17: 1031-1038.